Functional medicine
Biomarker Based PGx Strategies Rick Hockett, MD Chief Medical Officer Affymetrix.
Measuring Waiting Times – Understanding our destination and key milestones along the way Fiona Black Mental Health Programme Manager, ISD.
TAILORED THERAPIES: PROGNOSTIC & PREDICTIVE FACTORS F. Cardoso, MD Jules Bordet Institute, Brussels, Belgium BELGIAN BREAST MEETING 2008 October 4-5, 2008.
Effective Interventions for the Rehabilitation of Upper Extremity Cumulative Trauma Disorders Laura Jones Chism, OTS Spalding University January 24, 2014.
Different Strokes for Different Folks A Bayesian Approach to Heterogeneous Treatment Effects in Empirical Cost-Effectiveness Analysis Dave Vanness, Ph.D.
Dr. Fahd Al-Mulla ©2007. Understand that diseases (in most cases) are phenotypic representation of proteins quality and quantity disorders, either at.
Scope
NGP US 17